1-[(Benzyloxy)Carbonyl]-4-Hydroxypyrrolidine-2-Carboxylic Acid

When the 4-Hydroxy Substituent Determines Regioselectivity in 1,3-Dipolar Cycloaddition Reactions

The 4‑hydroxyl group within the Cbz-protected proline scaffold exerts a stereoelectronic directing effect in 1,3‑dipolar cycloadditions with nitrile oxides, enabling the construction of isoxazoline‑fused bicyclic peptidomimetics with predictable regio‑ and diastereochemistry. Cbz-Hyp-OH is first esterified with allyl bromide and Cs₂CO₃ in DMF at 0°C (6 h) to form the allyl ester, then oxidised with Dess–Martin periodinane (1.2 equiv) in dichloromethane at −20°C to furnish the Δ³,4‑dehydroproline derivative. Distillation of the α,β‑unsaturated ester is avoided owing to its propensity for thermal [1,5]‑sigmatropic rearrangement; instead, the crude product is passed through a short silica plug (hexane/EtOAc 7:3). Reaction with benzonitrile oxide, generated in situ from benzohydroximoyl chloride and triethylamine in dichloromethane at 0–5°C, proceeds with exclusive endo‑selectivity, giving the cis‑fused bicycle whose stereochemistry is secured by NOESY cross‑peaks between H‑3 and H‑6a. Regiochemical reversal is achieved when the hydroxyl is protected as a tert-butyldimethylsilyl ether; steric compression alters the LUMO coefficients at the dipolarophile, directing the reaction to the opposite regioisomer in a 9:1 ratio. The Cbz group withstands both the Dess‑Martin oxidation and the dipolar environment, and global deprotection is effected by transfer hydrogenation (Pd/C, ammonium formate, methanol, reflux, 1 h) without fragmentation of the isoxazoline ring. Published data for this specific 4‑hydroxyproline‑derived dipolarophile is limited, yet the methodology closely follows validation performed on 4‑azidoproline analogues and supports the expansion to other nitrile oxide dipoles.

Application in Large-Scale Peptide API Manufacturing Under cGMP

In commercial solid‑phase production of a 9‑residue cyclic peptide drug candidate featuring hydroxyproline at position‑5, the Cbz-Hyp-OH building block is introduced during linear assembly on a 2‑chlorotrityl chloride resin (CTC resin, initial loading 1.2 mmol/g). The synthesizer (CEM Liberty Blue, microwave mode) runs all standard couplings at 90°C for 2 min, but the Hyp coupling is deliberately run at 50°C to preserve the benzyl carbamate, a parameter enforced by a customised method file that overrides the default power setting. Activation is performed with 4.0 equiv of DIC and 4.0 equiv of ethyl cyano(hydroxyimino)acetate (Oxyma) in DMF; HOBt is excluded to avoid benzotriazole-related nitrosamine risks. The protected linear peptide is cleaved from the resin using 1% TFA in DCM, and solution‑phase cyclisation is executed with PyBOP/DIPEA at 1 mM substrate concentration in dichloromethane. The Cbz group is retained until after cyclisation to preclude any undesired N‑terminal participation. Final deprotection is performed in the same 50 L hydrogenation reactor described earlier, with 10% Pd/C (5% w/w) under 2 bar H₂ in methanol/water at 25°C for 3 h. Online ReactIR monitoring (Mettler Toledo ReactIR 45m, detector range 4000–650 cm⁻¹) tracks the disappearance of the carbamate carbonyl stretch at 1705 cm‑¹, allowing termination when intensity falls below 0.1% of its initial value, thus preventing over‑reduction and the formation of dimeric impurities that historically increased by 0.3% during extended hydrogenation.

All analytical methods applied to these batches are validated per ICH Q2(R1): linearity R² > 0.999, LOD for the D-allo‑Hyp impurity 0.02%, LOQ 0.05%. Palladium content is controlled by ICP‑MS under USP <233>, and the limit of 5 ppm is derived from the PDE (permitted daily exposure) calculation for the final drug product. The coupling reagent DIC is sourced with a purity specification of > 99% to constrain the urea by‑product that otherwise co‑elutes with the Cbz‑protected peptide during preparative HPLC. Operation under ICH Q7 guidelines requires that each batch of Cbz‑Hyp‑OH be subject to incoming identity testing by FT‑IR against an authenticated reference spectrum and impurity screening by reverse‑phase HPLC with the acceptance criterion of any single undefined impurity ≤ 0.15%. The major process‑related risk is the formation of 4‑hydroxyproline‑2,5‑diketopiperazine at the Hyp‑Pro junction when the coupling temperature drifts unintentionally above 60°C in alkaline media, a scenario prevented by the temperature‑controlled microwave algorithm.

How Does Residual Moisture Affect Cbz-group Integrity During Extended Storage?

Bulk storage of 1-[(Benzyloxy)carbonyl]-4-hydroxypyrrolidine-2-carboxylic acid under uncontrolled humidity triggers auto‑catalytic hydrolytic cleavage of the carbamate, a process sustained by the moderately acidic free carboxyl function (pKa calculated ~ 2.9). Accelerated stability trials conducted at 40°C/75% RH for 6 months in double LDPE bags enclosed within an HDPE drum show that degradation to free 4‑hydroxyproline is undetectable when initial water content (Karl Fischer, USP <921>) remains ≤ 0.3% w/w. If the moisture level surpasses 0.5% at the outset, free hydroxyproline escalates to 0.8% after 3 months, accompanied by benzyl alcohol and carbon dioxide evolution; benzyl alcohol is identified and quantified by headspace GC‑MS under chromatographic conditions aligned with USP <621>. Consequently, finished‑good intermediates are packaged in heat‑sealed aluminium‑laminated barrier bags containing silica gel desiccant sachets amounting to 10% of net weight, and the retest interval is set at 12 months in accordance with ISO 15378:2017 for primary packaging materials. The compound demonstrates incompatibility with alkaline‑earth metal cations, especially Ca²⁺ and Mg²⁺, which at elevated humidity chelate the Hyp carboxylate and promote decarboxylation; therefore, contact with cement floors or unprotected steel shelving is prohibited, and grade 316L stainless‑steel racking is specified in the handling SOP. Real‑time stability monitoring in ICH climatic zone II conditions (25°C/60% RH, ICH Q1A) confirms retention of potency ≥ 99.0% over 36 months in the prescribed packaging, with no microbial outgrowth attributable to the material’s intrinsically low water activity (aw < 0.6).

Exploring This Building Block as a Substrate for Enzymatic Resolution

1-[(Benzyloxy)carbonyl]-4-hydroxypyrrolidine-2-carboxylic acid, following conversion to its ethyl ester, serves as a competent substrate for Candida antarctica lipase B (CAL‑B) in kinetic resolution protocols designed to upgrade enantiomeric purity of the desired (2S,4R)-cis diastereomer from racemic trans‑4‑hydroxyproline. Racemic Cbz‑Hyp‑OH is prepared by Schotten–Baumann carbamoylation of the inexpensive dl‑trans‑4‑hydroxyproline with benzyl chloroformate, then esterified with ethanol/thionyl chloride at 0°C to yield the racemic ethyl ester. The ester is dissolved in MTBE that has been dried to <0.1% water over activated 3Å molecular sieves, vinyl acetate is added as the acyl donor (2.0 equiv), and CAL‑B immobilised on acrylic resin (Novozym 435, 20% w/w) is suspended in the mixture. Stirring at 30°C for 24 h results in preferential acetylation of the (2S,4R) enantiomer, while the unreacted (2R,4S) antipode remains. Chromatographic separation on silica gel (hexane/ethyl acetate gradient) isolates the unreacted alcohol with an enantiomeric excess of 96% e.e. as determined by chiral HPLC (Chiralcel OD‑H, n‑hexane/isopropanol 90:10). Subsequent saponification with LiOH in THF/water at 0°C (30 min) regenerates the free (2R,4S)-Cbz‑Hyp‑OH, which can be crystallised from ethyl acetate/hexane to achieve optical purity. This enzymatic resolution obviates classical diastereomeric salt formation with expensive chiral amines and eliminates trace metal contamination, an advantage for peptide APIs that must meet ICH Q3D elemental impurity limits. The primary operational constraint is the strict control of water in the reaction medium: if the Karl Fischer value drifts above 0.1%, the equilibrium shifts toward ester hydrolysis rather than transesterification, collapsing the enantioselectivity factor (E) to < 5. Published data for this specific Cbz‑protected hydroxyproline ethyl ester–CAL‑B system is limited, but the performance metrics align with those reported for analogous N‑protected proline esters.